Kanagawa, Japan

Masahiro Urushihara

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Mitsubishi Pharma Corporation. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Urushihara. Retrieved from https://idiyas.com/inventor/masahiro-urushihara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masahiro Urushihara: Innovator in Prostaglandin Derivative Production

Introduction

Masahiro Urushihara is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the production of prostaglandin derivatives. His innovative approach has led to advancements that benefit various medical applications.

Latest Patents

Urushihara holds a patent for a process that produces a purified prostaglandin derivative. The method involves adding an alkene to cyclopentenone under the influence of an alkyl lithium and an organic copper reagent. This reaction forms an adduct, which is then treated with a carboxylic anhydride to yield the desired prostaglandin derivative. The process further includes the use of a nitrogen-containing compound to efficiently remove the organic copper reagent and its by-products, resulting in a high-purity product.

Career Highlights

Masahiro Urushihara is associated with Mitsubishi Pharma Corporation, where he has been instrumental in research and development. His work has not only contributed to the company's portfolio but has also advanced the field of pharmaceutical chemistry.

Collaborations

Urushihara collaborates with fellow researcher Yoshitomi Morizawa, enhancing the innovative efforts within their team. Their combined expertise fosters a productive environment for developing new pharmaceutical solutions.

Conclusion

Masahiro Urushihara's contributions to the production of prostaglandin derivatives exemplify the impact of innovation in the pharmaceutical industry. His work continues to influence advancements in medical treatments and showcases the importance of research and collaboration in achieving significant breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…